4//SEC Filing
Ruth Matthew R. 4
Accession 0001385508-22-000099
CIK 0001385508other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 4:01 PM ET
Size
5.0 KB
Accession
0001385508-22-000099
Insider Transaction Report
Form 4
Ruth Matthew R.
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-06-27+2,000→ 31,000 total
Footnotes (1)
- [F1]Represents the acquisition of shares upon the determination on June 27, 2020 by the Compensation and Human Capital Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to a portion of the performance stock units granted to the Reporting Person on January 4, 2022.
Documents
Issuer
OPIANT PHARMACEUTICALS, INC.
CIK 0001385508
Entity typeother
Related Parties
1- filerCIK 0001872022
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 4:01 PM ET
- Size
- 5.0 KB